Xeris Biopharma Statistics
NASDAQ: XERSHealthcareDrug Manufacturers - Specialty & GenericUSD
10.19+0.08 (+0.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Xeris Biopharma by the numbers
Xeris Biopharma has a market capitalization of $1.86 billion based on 182.32M shares outstanding. With trailing EPS of $-0.10, Xeris Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.9% above its 50-day average and 40.7% above its 200-day average.
Average daily trading volume is 2.17M shares, or about $22.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XERS valuation vs. peer median
| Metric | XERS | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.86B | $484.16M | +284% |
| Forward P/E | 27.5 | 26.7 | +3% |
| Avg. volume | 2.17M | 1.02M | +114% |
Peer median across 8 companies: ETON, CRON, AQST, EOLS, TKNO, CGC, ACB, CPIX.
Valuation
- Market cap
- $1.86B
- Forward P/E
- 27.54
- EPS (TTM)
- $-0.10
- Shares outstanding
- 182.32M
Price and trading
- Previous close
- 10.11
- Open
- 10.10
- Day range
- 10.00 – 10.35
- 52-week range
- 5.25 – 11.33
- 52-week change
- +22.10%
- Beta
- —
- Volume
- 1.91M
- Average volume
- 2.17M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.86B
- Forward Pe
- 27.54
- Eps
- -0.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.33
- Week52 Low
- 5.25
- Avg Volume
- 2.17M
- Shares Outstanding
- 182.32M
- Ma50
- 8.57
- Ma200
- 7.24
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -10.06%
- Pct From52w Low
- 94.10%